About Matthew Cooper
Matthew Cooper is a co-founder & chief scientific officer at Allotera Therapeutics.
Matthew Cooper first appears on SEC filings in 2021.
Experience
This experience comes from Matthew Cooper's profile and from SEC filings. For roles taken from filings, the years are when the filings name Matthew Cooper in the role, so the role may have started earlier or lasted longer.
Allotera Therapeutics, Inc. Current
Co-Founder & Chief Scientific Officer
2018 – Present · St. Louis, MO
Develops donor-cell therapies for people with blood cancers.
WL
Washington University School of Medicine in St. Louis
Adjunct Assistant Professor (2014 – 2023)
Postdoctoral Research Associate (2011 – 2014)
2011 – 2023
Key Colleagues at Startups
The people Matthew Cooper works with at each company, as listed on that company's latest Form D.
Allotera Therapeutics, Inc. · Form D/A, Jul 23, 2026
DD
Drew Dennison
Director
KL
Kevin Li
Director
NM
Natalie Mount
Director
ND
Niall O'Donnell
Director
Kumar Srinivasan
President & Chief Executive Officer, director
BH
Bosun Hau
Director
PK
Peter Kiener
Chair
Cherry Thomas
Chief Medical Officer
Ayman Kabakibi
Chief Operating Officer & EVP, R&D
BM
Bali Muralidhar
Director